Pulse Biosciences Inc.

15.96
-0.13 (-0.81%)
At close: Apr 01, 2025, 3:59 PM
16.29
2.08%
After-hours: Apr 01, 2025, 07:56 PM EDT

Pulse Biosciences Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue n/a n/a 700K 1.42M n/a
Cost of Revenue n/a 1.21M 11.94M 1.97M 665K
Gross Profit n/a -1.21M -11.24M -550K -665K
Operating Income -56.26M -43.57M -58.06M -63.01M -49.97M
Interest Income n/a n/a 263K 646K 114K
Pretax Income -53.59M -42.21M -58.51M -63.66M -49.85M
Net Income -53.59M -42.21M -58.95M -63.16M -49.74M
Selling & General & Admin 23.92M 15.78M 25.97M 33.82M 22.86M
Research & Development 32.34M 27.8M 20.84M 28.64M 26.44M
Other Expenses n/a n/a n/a n/a 665K
Operating Expenses 56.26M 43.57M 46.81M 62.46M 49.97M
Interest Expense n/a 1.36M 448K 646K n/a
Selling & Marketing Expenses n/a n/a 12.02M 14.75M 7.26M
Cost & Expenses 56.26M 43.57M 58.76M 64.43M 49.97M
Income Tax -53.59M n/a 448K -500K -114K
Shares Outstanding (Basic) 58.4M 48.04M 33.94M 27.96M 23.25M
Shares Outstanding (Diluted) 58.4M 48.04M 33.94M 27.96M 23.25M
EPS (Basic) -0.92 -0.88 -1.74 -2.26 -2.14
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -56.26M -42.37M -56.7M -61.87M -48.87M
Depreciation & Amortization n/a 1.21M 1.35M 1.15M 1.09M